Antares Pharma CEO Robert Apple's 2019 pay rises 2% to $3.5M
Antares Pharma reports 2019 executive compensation
By ExecPay News
Published: April 27, 2020
Antares Pharma reported fiscal year 2019 executive compensation information on April 27, 2020.
In 2019, four executives at Antares Pharma received on average a compensation package of $1.8M, a 11% increase compared to previous year.
Average pay of disclosed executives at Antares Pharma
Robert F. Apple, Chief Executive Officer, received $3.5M in total, which increased by 2% compared to 2018. 47% of Apple's compensation, or $1.7M, was in stock awards. Apple also received $427K in non-equity incentive plan, $850K in option awards, $572K in salary, as well as $14K in other compensation.
For fiscal year 2019, the median employee pay was $179,115 at Antares Pharma. Therefore, the ratio of Robert F. Apple's pay to the median employee pay was 20 to one.
Fred M. Powell, Chief Financial Officer, received a compensation package of $1.4M, which increased by 5% compared to previous year. 38% of the compensation package, or $528K, was in stock awards.
Peter J. Graham, General Counsel, earned $1.4M in 2019, a 1% increase compared to previous year.
James P. Tursi, Chief Medical Officer, received $1.1M in 2019, which increases by 118% compared to 2018.
Related executives
You may also like
Source: SEC filing on April 27, 2020.